Tianjin Chase Sun Pharmaceutical Co., Ltd. logo

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
3. 56
+0.15
+4.3988%
¥
11.18B Market Cap
- P/E Ratio
0.12% Div Yield
54.5M Volume
- Eps
¥ 3.41
Previous Close
Add Transaction
Day Range
3.42 3.59
Year Range
2.82 4.44
Want to track 300026 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300026 trading today higher at ¥3.56, an increase of 4.3988% from yesterday's close, completing a monthly increase of 22.7586% or ¥0.66. Over the past 12 months, 300026 stock gained 0.565%.
300026 pays dividends to its shareholders, with the most recent payment made on Jul 15, 2026. The next estimated payment will be in In 11 months on Jul 15, 2027 for a total of ¥0.01.
The last earnings report, released on Oct 24, 2024, exceeded the consensus estimates by 0.0067%. On average, the company has surpassed earnings expectations by 0.0187%, based on the last three reports.
Tianjin Chase Sun Pharmaceutical Co., Ltd. has completed 7 stock splits, with the recent split occurring on Oct 26, 2016.
The company's stock is traded on one exchange.

300026 Chart

People also search for

Weichai Power Co., Ltd.
¥ 31.27
-2.5249%
Chongqing Changan Automobile Co., Ltd.
¥ 7.4
-0.2695%
Yunnan Baiyao Group Co., Ltd.
¥ 51.38
+0.3712%
Tianqi Lithium Corporation
¥ 48.24
-1.3699%
Guangzhou Tinci Materials Technology Co., Ltd.
¥ 39.6
-0.0505%

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026) FAQ

What is the stock price today?

The current price is ¥3.56.

On which exchange is it traded?

Tianjin Chase Sun Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300026.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, the market cap is 11.18B.

Has Tianjin Chase Sun Pharmaceutical Co., Ltd. ever had a stock split?

Tianjin Chase Sun Pharmaceutical Co., Ltd. had 7 splits and the recent split was on Oct 26, 2016.

Tianjin Chase Sun Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Wu Jun Lan CEO
XSHE Exchange
CNE100000GF1 ISIN
CN Country
5,297 Employees
15 Jul 2026 Last Dividend
26 Oct 2016 Last Split
30 Oct 2009 IPO Date

Overview

Tianjin Chase Sun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company that has been at the forefront of healthcare innovation since its establishment in 1996. With its headquarters in Tianjin, China, the company has grown to have a wide-reaching impact both domestically and internationally. Its core activities encompass the research, development, production, and marketing of a diverse range of pharmaceutical products. By focusing on critical healthcare segments, Tianjin Chase Sun aims to contribute significantly to improving the quality of life for patients worldwide, exhibiting a strong commitment to addressing pressing health issues with effective solutions.

Products and Services

Tianjin Chase Sun Pharmaceutical Co., Ltd. offers a diverse portfolio of products and services tailored to meet the complex needs of the healthcare industry, including:

  • Chinese Medicine Granules: These are formulations based on traditional Chinese medicine principles, processed into granules for ease of consumption and enhanced bioavailability. The company utilizes advanced technology to ensure the purity and efficacy of these products.
  • Finished Pharmaceutical Products: The company manufactures a variety of prescription medications and over-the-counter (OTC) products that address a range of health conditions, ensuring high-quality standards and compliance with regulatory requirements.
  • Raw Materials and Excipients: Tianjin Chase Sun provides essential ingredients required for pharmaceutical manufacturing, including active pharmaceutical ingredients (APIs) and excipients. These materials are critical for the development and production of effective and safe medications.
  • Medical Devices: The company extends its healthcare solutions portfolio by offering medical devices. These include a range of instruments, apparatus, and machinery designed to diagnose, prevent, monitor, treat, or alleviate health conditions.
  • Healthcare Services: Recognizing the importance of comprehensive care, Tianjin Chase Sun offers various healthcare services to support patients and healthcare providers. This includes clinical research, pharmaceutical logistics, and other service-oriented solutions that complement their product offerings.
  • Smart Supply Chain for Pharmaceuticals and Medical Devices: Leveraging the latest in technology, the company implements smart supply chain solutions to enhance the efficiency and reliability of pharmaceutical and medical device distribution. This initiative ensures timely delivery of essential healthcare products to markets and healthcare facilities.

Focusing on areas such as severe disease, cardiovascular, cerebrovascular system, respiratory system, neurodegenerative conditions, and anti-tumor treatments, Tianjin Chase Sun Pharmaceutical Co., Ltd. is dedicated to advancing healthcare outcomes through innovation and quality.

Contact Information

Address: Building B01, Entrepreneurial Headquarters Base, Tianjin, China, 301700
Phone: 86 22 5962 3160